← Back to Health Technology

Pharmaceuticals: Major

Industry Overview

Stock Screener

Select filters to narrow down the 26 companies below

26 companies
$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap $2.62T
Dividends 1.9%
P/E Ratio 25.6
Revenue $15.4B +6.4%
Net Income $2.51B +2.3%
Profit Margin +16.3%
Employees 96.1K
View Stock
Market Cap $2.62T
Dividends 1.9%
P/E Ratio 25.6
Revenue $15.4B +6.4%
Net Income $2.51B +2.3%
Profit Margin +16.3%
Employees 96.1K
View Stock
Market Cap $2.62T
Dividends 1.9%
P/E Ratio 25.6
Revenue $15.4B +6.4%
Net Income $2.51B +2.3%
Profit Margin +16.3%
Employees 96.1K
View Stock
Market Cap $2.62T
Dividends 1.9%
P/E Ratio 25.6
Revenue $15.4B +6.4%
Net Income $2.51B +2.3%
Profit Margin +16.3%
Employees 96.1K
View Stock
Market Cap $2.62T
Dividends 1.9%
P/E Ratio 25.6
Revenue $15.4B +6.4%
Net Income $2.51B +2.3%
Profit Margin +16.3%
Employees 96.1K
View Stock
Market Cap $392.65B
Dividends 2.5%
P/E Ratio 25.4
Revenue $30.2B -5.2%
Net Income $6.83B -7.8%
Profit Margin +22.6%
Employees 103.25K
View Stock
Market Cap $392.65B
Dividends 2.5%
P/E Ratio 25.4
Revenue $30.2B -5.2%
Net Income $6.83B -7.8%
Profit Margin +22.6%
Employees 103.25K
View Stock
Market Cap $392.65B
Dividends 2.5%
P/E Ratio 25.4
Revenue $30.2B -5.2%
Net Income $6.83B -7.8%
Profit Margin +22.6%
Employees 103.25K
View Stock
Market Cap $392.65B
Dividends 2.5%
P/E Ratio 25.4
Revenue $30.2B -5.2%
Net Income $6.83B -7.8%
Profit Margin +22.6%
Employees 103.25K
View Stock
Market Cap $392.65B
Dividends 2.5%
P/E Ratio 25.4
Revenue $30.2B -5.2%
Net Income $6.83B -7.8%
Profit Margin +22.6%
Employees 103.25K
View Stock
Market Cap $392.65B
Dividends 2.5%
P/E Ratio 25.4
Revenue $30.2B -5.2%
Net Income $6.83B -7.8%
Profit Margin +22.6%
Employees 103.25K
View Stock
Market Cap $392.65B
Dividends 2.5%
P/E Ratio 25.4
Revenue $30.2B -5.2%
Net Income $6.83B -7.8%
Profit Margin +22.6%
Employees 103.25K
View Stock
Market Cap $392.65B
Dividends 2.5%
P/E Ratio 25.4
Revenue $30.2B -5.2%
Net Income $6.83B -7.8%
Profit Margin +22.6%
Employees 103.25K
View Stock
Market Cap $287.24B
Dividends 2.9%
P/E Ratio 23.6
Revenue $14.1B -5.0%
Net Income $3.19B -21.0%
Profit Margin +22.7%
Employees 75.27K
View Stock
Market Cap $287.24B
Dividends 2.9%
P/E Ratio 23.6
Revenue $14.1B -5.0%
Net Income $3.19B -21.0%
Profit Margin +22.7%
Employees 75.27K
View Stock
Market Cap $287.24B
Dividends 3.1%
P/E Ratio 21.8
Revenue $14.1B -5.0%
Net Income $3.19B -21.0%
Profit Margin +22.7%
Employees 75.27K
View Stock
Market Cap $287.24B
Dividends 3.1%
P/E Ratio 21.8
Revenue $14.1B -5.0%
Net Income $3.19B -21.0%
Profit Margin +22.7%
Employees 75.27K
View Stock
Market Cap $99.68B
Dividends 11.2%
P/E Ratio 22.7
Revenue $12.3B +14.6%
Net Income $343M -91.3%
Profit Margin +2.8%
Employees 74.85K
View Stock
Market Cap $99.68B
Dividends 11.2%
P/E Ratio 22.7
Revenue $12.3B +14.6%
Net Income $343M -91.3%
Profit Margin +2.8%
Employees 74.85K
View Stock
Market Cap $99.68B
Dividends 11.7%
P/E Ratio 21.9
Revenue $12.3B +14.6%
Net Income $343M -91.3%
Profit Margin +2.8%
Employees 74.85K
View Stock